New Use for Semaglutide Recent research has shown that the popular GLP-1 weight loss drug, semaglutide, may halt and even reverse severe liver disease in some patients
Clinical trials have shown it can help manage neuropathic pain
Thank you to our sponsors AG1 (Athletic Greens): InsideTracker: Thesis: Supplements from Momentous For the full show notes, visit hubermanlab.com Timestamps (00:00:00) Your Sense of Self: Interoception (00:01:25) Protocol 1: Fermented Foods, Not Fiber, to Reduce Inflammation (00:03:30) Attributions (00:08:22) Main Drivers of Feelings & Performance (00:11:45) Brain-Body: A Mechanical & Chemical Dialogue (00:17:50) LDB (Lung-Diaphragm-Brain) Dialogue (00:21:00) Protocols 2, 3, 4: Control Heart Rate With Breathing (00:29:08) Sensing Lung Pressure: Piezo Receptors (00:30:54) Carbon Dioxide, From Air to Blood (00:34:02) Protocol 5: Alert While Calm (00:40:50) Baroreceptors: Hering-Breuer Reflex (00:42:47) Gut Volume & The Desire to Open Your Mouth (00:48:18) Protocol 6: Enhancing Gut-To-Brain Communication, Fasting (00:51:50) Intestines, Fatty Acids, Amino Acids & Sugar (00:57:00) Protocol 7: Reducing Sugar Cravings with Specific Amino Acid Nutrients (00:58:58) Gut Acidity (Is Good) (01:02:20) Improving Nasal Microbiome (01:04:13) Inflammation & Microbiome: Fiber vs
Clarifying the difference of metabolic profiles and of molecular mechanisms between HFrEF and HFpEF might provide clinical significance of carnitine metabolism as new therapeutic target for metabolic disorder in hypertensive HFpEF, remaining unmet medical needs in cardiovascular medicine
That's why we offer convenient weekly payment options for eligible GLP-1 weight loss medications, including Semaglutide and Tirzepatide
